Literature DB >> 23808814

Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan.

Hiroshi Kimura1, Kennosuke Karube, Yoshinori Ito, Kyoko Hirano, Michio Suzuki, Seiko Iwata, Masao Seto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23808814     DOI: 10.3109/10428194.2013.819577

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


× No keyword cloud information.
  15 in total

1.  Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells.

Authors:  Can Küçük; Bei Jiang; Xiaozhou Hu; Wenyan Zhang; John K C Chan; Wenming Xiao; Nathan Lack; Can Alkan; John C Williams; Kendra N Avery; Pınar Kavak; Anna Scuto; Emel Sen; Philippe Gaulard; Lou Staudt; Javeed Iqbal; Weiwei Zhang; Adam Cornish; Qiang Gong; Qunpei Yang; Hong Sun; Francesco d'Amore; Sirpa Leppä; Weiping Liu; Kai Fu; Laurence de Leval; Timothy McKeithan; Wing C Chan
Journal:  Nat Commun       Date:  2015-01-14       Impact factor: 14.919

2.  Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma.

Authors:  Lu Jiang; Zhao-Hui Gu; Zi-Xun Yan; Xia Zhao; Yin-Yin Xie; Zi-Guan Zhang; Chun-Ming Pan; Yuan Hu; Chang-Ping Cai; Ying Dong; Jin-Yan Huang; Li Wang; Yang Shen; Guoyu Meng; Jian-Feng Zhou; Jian-Da Hu; Jin-Fen Wang; Yuan-Hua Liu; Lin-Hua Yang; Feng Zhang; Jian-Min Wang; Zhao Wang; Zhi-Gang Peng; Fang-Yuan Chen; Zi-Min Sun; Hao Ding; Ju-Mei Shi; Jian Hou; Jin-Song Yan; Jing-Yi Shi; Lan Xu; Yang Li; Jing Lu; Zhong Zheng; Wen Xue; Wei-Li Zhao; Zhu Chen; Sai-Juan Chen
Journal:  Nat Genet       Date:  2015-07-20       Impact factor: 38.330

Review 3.  Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders.

Authors:  Geoffrey Shouse; Liana Nikolaenko
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 3.952

4.  EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma.

Authors:  Ji Yun Lee; Joo Hyun Kim; Heejin Bang; Junhun Cho; Young Hyeh Ko; Seok Jin Kim; Won Seog Kim
Journal:  Sci Rep       Date:  2021-05-14       Impact factor: 4.379

Review 5.  Molecular Pathogenesis of Peripheral T Cell Lymphoma.

Authors:  Mamiko Sakata-Yanagimoto; Shigeru Chiba
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 4.213

Review 6.  Disease-specific mutations in mature lymphoid neoplasms: recent advances.

Authors:  Mamiko Sakata-Yanagimoto; Terukazu Enami; Yasuhisa Yokoyama; Shigeru Chiba
Journal:  Cancer Sci       Date:  2014-05-12       Impact factor: 6.716

7.  Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type.

Authors:  Seungbok Lee; Ha Young Park; So Young Kang; Seok Jin Kim; Jinha Hwang; Seungho Lee; Soo Heon Kwak; Kyong Soo Park; Hae Yong Yoo; Won Seog Kim; Jong-Il Kim; Young Hyeh Ko
Journal:  Oncotarget       Date:  2015-07-10

8.  STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target.

Authors:  Erika Onozawa; Haruna Shibayama; Honami Takada; Ken-Ichi Imadome; Sho Aoki; Mayumi Yoshimori; Norio Shimizu; Shigeyoshi Fujiwara; Takatoshi Koyama; Osamu Miura; Ayako Arai
Journal:  Oncotarget       Date:  2018-07-24

Review 9.  The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation.

Authors:  Sanjay de Mel; Gwyneth Shook-Ting Soon; Yingting Mok; Tae-Hoon Chung; Anand D Jeyasekharan; Wee-Joo Chng; Siok-Bian Ng
Journal:  Int J Mol Sci       Date:  2018-06-30       Impact factor: 5.923

Review 10.  Aggressive NK-Cell Leukemia.

Authors:  Fumihiro Ishida
Journal:  Front Pediatr       Date:  2018-10-10       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.